Car T-cell

Engineered Immune Cells Target Solid Tumors via Metabolites

In-Vivo CAR T Cell Breakthrough—But How Far From Patients?

Lab-grown CAR T cells bypass external editing—preclinical success against 3 cancers, a major leap for solid tumors.